General
South African variant of COVID-19 can ‘break through’ Pfizer vaccine, Israeli study says
The coronavirus variant discovered in South Africa can “break through” the Pfizer COVID-19 vaccine to some extent, a real-world data study in Israel has found, though its prevalence in the country is low and the research has not been peer reviewed.
Key points:
The study, released on Saturday, compared almost 400 people who had tested positive for COVID-19, 14 days or more after they received one or two doses of the vaccine, against the same number of unvaccinated patients with the disease.
It matched age and gender, among other characteristics.
The South African variant, B.1.351, was found to make up about 1 per cent of all the COVID-19 cases across all the people studied, according to the study by Tel Aviv University and Israel’s largest…
-
Noosa News23 hours agoTranslink data shows buses are late more often as Queensland approaches one year of 50¢ fares
-
General21 hours agoAustralia’s social media ban is a slippery slope
-
General23 hours agoRivers of gold pour into Kalgoorlie for mining forum
-
Noosa News13 hours agoGillick competency, the courts and parental consent: What are the steps for a teenager to get an abortion?